Myelofibrosis Diagnosis and Evaluation

What Are Stem Cells? A Guide to Regenerative Medicine

Stem cells can develop into many cell types and act as the body’s repair system. They replace or restore damaged tissues, offering new possibilities for treating diseases.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

The Diagnostic Challenge

Diagnosing myelofibrosis requires a meticulous synthesis of clinical observations, microscopic pathology, and advanced molecular genetics. It is a diagnosis of inclusion, meaning specific criteria must be met, but also a diagnosis of exclusion, as other conditions (such as metastatic cancer, infections, or autoimmune disorders) can also cause marrow fibrosis. The evaluation must be comprehensive to distinguish Primary Myelofibrosis (PMF) from other Myeloproliferative Neoplasms (MPNs) and to accurately stage the severity of the fibrosis, as this directly impacts the transplant strategy.

The Diagnostic Challenge​
Icon LIV Hospital

Peripheral Blood Evaluation: The Leukoerythroblastic Picture

Peripheral Blood Evaluation: The Leukoerythroblastic Picture

Abnormalities often raise suspicion of myelofibrosis on routine Complete Blood Count (CBC) and peripheral blood smear examination.

  • Anemia: Most patients present with anemia (low hemoglobin), which is often progressive.
  • Variable White Cell and Platelet Counts: Unlike leukemia, which typically presents with high or low counts, MF is characterized by variable counts. Counts can be very high initially (cellular phase) or very low (fibrotic phase).
  • Leukoerythroblastosis: This is a hallmark finding on the blood smear. It refers to the presence of immature white blood cells (myelocytes, metamyelocytes) and immature nucleated red blood cells in the circulating blood. Usually, the bone marrow retains these cells until they are mature. Their presence in the blood indicates that the marrow barrier is breached or that blood is being produced in extramedullary sites, such as the spleen, which lacks the marrow’s filtration system.
  • Dacrocytes (Teardrop Cells): Pathologists look for red blood cells that are teardrop-shaped. This characteristic shape is believed to result from red cells being mechanically squeezed and distorted as they try to push through the fibrotic meshwork of the scarred bone marrow.
Icon 1 LIV Hospital

Bone Marrow Aspiration and Biopsy

Bone Marrow Aspiration and Biopsy

The definitive diagnosis relies on examining the bone marrow architecture.

  • The “Dry Tap”: A clinical clue often occurs during the aspiration procedure. Because the marrow is scarred and fibrotic, the liquid marrow cannot be withdrawn with a needle. This failure to obtain liquid is known as a “dry tap” and is highly suggestive of myelofibrosis.
  • Histopathology and Grading: The core biopsy (solid tissue) is essential. Pathologists stain tissue with silver stains (reticulin) and trichrome stains (collagen) to visualize fibers. The fibrosis is graded on a scale from MF-0 to MF-3.
  • MF-0: Scattered linear reticulin with no intersections.
  • MF-1: Loose network of reticulin with many intersections.
  • MF-2: Diffuse and dense increase in reticulin with extensive intersections, sometimes with focal bundles of collagen.
  • MF-3: Dense diffuse reticulin and coarse bundles of collagen, often with new bone formation (osteosclerosis).
  • Megakaryocyte Morphology: The biopsy also reveals clustered, large megakaryocytes with bizarrely shaped nuclei (hyperchromatic and bulbous).
Icon LIV Hospital

Molecular Genetics and Next-Generation Sequencing (NGS)

Molecular Genetics and Next-Generation Sequencing (NGS)

Modern diagnosis is incomplete without genetic profiling. The World Health Organization (WHO) criteria require the presence of a “driver mutation” or evidence of clonality.

  • Driver Mutations: Testing is performed for the three canonical driver mutations:
  • JAK2 V617F: Present in approx. 50-60% of patients.
  • CALR (Calreticulin): Present in approx. 20-25% of patients.
  • MPL: Present in approx. 5-10% of patients.
  • Triple Negative: About 10-15% of patients lack all three mutations. In these cases, NGS is crucial for identifying additional mutations (such as ASXL1, EZH2, TET2, and SRSF2) to confirm that the disease is clonal and not reactive.
  • Prognostic Implications: The specific mutation matters. Patients with CALR mutations generally have a better prognosis than those with JAK2 or MPL mutations. Patients who are “Triple Negative” tend to have more aggressive disease.
Icon 1 LIV Hospital

Physical Examination and Imaging

Physical Examination and Imaging​

Evaluating the extent of extramedullary disease is part of the workup.

  • Splenomegaly Assessment: Physical palpation of the abdomen is used to measure the spleen’s size below the rib cage. In massive splenomegaly, the spleen can extend into the pelvis.
  • Ultrasound/CT/MRI: While a physical exam is standard, imaging helps precisely quantify the volumes of the spleen and liver. This is useful for monitoring the response to therapies aimed at shrinking these organs. MRI can also detect extramedullary hematopoiesis in other areas, such as the spinal column, which can compress nerves.

Cytogenetics

Chromosomal analysis (karyotyping) is performed on the bone marrow cells (if obtainable) or peripheral blood.

  • Abnormalities: Common findings include deletions of 13q or 20q, or partial trisomy of 1q.
  • Complex Karyotypes: The presence of complex chromosomal rearrangements indicates a very high risk of transformation to leukemia and poor overall survival, prompting urgent consideration for stem cell transplant.
Diagnosis and Evaluation img 6 LIV Hospital

30
Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical expertise and hospitality to every individual who walks through our doors.  

Book a Free Certified Online Doctor Consultation

Doctors

Table of Contents

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

What is a “dry tap” during a bone marrow biopsy?

A dry tap occurs when the doctor inserts a needle into the bone to withdraw marrow, but no fluid comes out. In myelofibrosis, the marrow space is filled with scar tissue and fibers rather than the usual liquid, sponge-like material. This inability to aspirate fluid is a classic sign of the disease.

Teardrop cells, or dacrocytes, are red blood cells that have been misshapen into a droplet form. This happens because they are mechanically damaged as they try to squeeze through the fibrosis (scar tissue) in the bone marrow to enter the bloodstream. They are seen under a microscope and are a hallmark of marrow scarring.

Fibrosis can be caused by other conditions, such as infections, autoimmune diseases, or cancers that spread to the bone. Genetic testing (for JAK2, CALR, MPL) confirms that the fibrosis is caused by a primary blood cancer (myelofibrosis) and not a secondary reaction to another illness.

Triple Negative means the patient tests negative for the three most common driver mutations: JAK2, CALR, and MPL. These patients still have myelofibrosis, but other, less common mutations drive it. Triple-negative status is generally associated with a more aggressive disease course and a poorer prognosis.

Yes, a palpable spleen is a primary diagnostic criterion. While not every patient has an enlarged spleen, its presence, especially when combined with marrow fibrosis and genetic mutations, strongly supports the diagnosis. The size of the spleen also helps doctors track how well the treatment is working.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Contact Us to Get Information!

Contact
Your Comparison List (you must select at least 2 packages)